Tharimmune Inc (THAR)
4.25
-0.32
(-7.07%)
USD |
NASDAQ |
May 28, 10:49
Tharimmune Total Assets (Quarterly): 8.887M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.887M |
| December 31, 2023 | 10.95M |
| September 30, 2023 | 3.167M |
| June 30, 2023 | 4.599M |
| March 31, 2023 | 4.722M |
| December 31, 2022 | 6.689M |
| September 30, 2022 | 7.833M |
| Date | Value |
|---|---|
| June 30, 2022 | 9.786M |
| March 31, 2022 | 11.36M |
| December 31, 2021 | 0.6217M |
| September 30, 2021 | 0.4149M |
| June 30, 2021 | 0.2831M |
| December 31, 2020 | 0.2948M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.2831M
Minimum
Jun 2021
11.36M
Maximum
Mar 2022
5.354M
Average
4.722M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 438.82M |
| Mirum Pharmaceuticals Inc | 651.96M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.838M |
| Shareholders Equity (Quarterly) | 7.049M |